Skip to content

Scailyte and CHU Rennes partnership for identifying Covid-19 patients

Scailyte and CHU Rennes have made an initial discovery of a single-cell biomarker for identification of covid19 patients at risk to become critically ill. We strive to deliver diagnostics that will allow pro-active clinical decisions and improve the outcome for Covid19 patients.

Recent News

Recent News

ETH Industry E-Week 2020 features Scailyte with the headline: Using Artificial Intelligence to unlock the clinical potential of single-cell data.

As ETH- Spin-off Scailyte attends the 2020 Industry eWeek giving updates on the disease area focus,

Read more

Recent News

Interview with Scailyte’s CEO Peter Nestorov

In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO

Read more

Recent News

Interview with Scailyte Founder Prof. Dr. Manfred Claassen

In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri

Read more

Recent News

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Read more

Recent News

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Read more

Recent News

Scailyte closes pre-series A financing round

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to furthe

Read more

Recent News

01 /04

Recent News

02 /04

Interview with Scailyte’s CEO Peter Nestorov

In the interview done by Venturelab, Peter talks about the challenges of an entrepreneur. As the CEO

Read more

Recent News

03 /04

Interview with Scailyte Founder Prof. Dr. Manfred Claassen

In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen descri

Read more

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare

Read more

Recent News

04 /04

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase th

Read more

Scailyte closes pre-series A financing round

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to furthe

Read more

Recent News